Regen BioPharma, Inc. Discusses Recent Developments in Aplastic Anemia Therapy and Future Potential Expansion of HemaXellerate

SAN DIEGO, May 11, 2016 -- (Healthcare Sales & Marketing Network) -- Regen BioPharma, Inc., (RGBP), (RGBP) and (RGBPP) announced today that potential market expansion of its HemaXellerate therapy for aplastic anemia is a strategic priority. The Compan... Biopharmaceuticals, Regenerative MedicineRegen BioPharma, HemaXellerate, aplastic anemia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news